FCF Life Sciences Venture Capital Monitor – Europe 06/2021 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 06/2021”.

The Monitor is a monthly published overview of venture capital trends in the European Life Sciences sector.

As of the end of June 2021, we identify the following current VC trends in Europe:

  • In 2021, overall Life Sciences funding has reached EUR 7,330m so far
  • Top 5 Deals exceed EUR 190m each, largest transaction amounted to EUR 253m in CMR Surgical Ltd. (United Kingdom)
  • BlackRock (USA) still dominates the Top 5 Investors (by deal volume), followed by Fidelity Management & Research (USA) and Novo Holdings (Denmark)
  • The Biotechnology sector received 49% of the total investment volume (-8% points compared to the previous month)
  • Oncology overtakes Central Nervous System as the top indication

To access the full report, please click here.

By Dr. Mathias Schott, Sebastian Sommer and Alexander Kuhn

Share on linkedin
Scroll Up